NDC 63323-010-01 - Gentamicin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-010
- Requested NDC
- 63323-010-01
- Package NDCs from labels
- 63323-010-96, 63323-010-41, 63323-010-94, 63323-010-42, 63323-010-95, 63323-010-01, 63323-010-02, 63323-010-03, 63323-010-20
- Manufacturer
- Henry Schein, Inc
- Effective date
- 2026-11-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gentamicin - Henry Schein, Inc | Henry Schein, Inc | 2026-11-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-10-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin Injection, USP | REMEDYREPACK INC. | 2024-10-10 | HUMAN PRESCRIPTION DRUG LABEL |
| GENTAMICIN - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-11-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-10-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Gentamicin - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-010-01 | Gentamicin | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 7 | |
| 63323-010-02 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-010-03 | Gentamicin | 20 mL in 1 VIAL | INJECTION, SOLUTION | 20 | 7 | |
| 63323-010-20 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-010-41 | Gentamicin | 2 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 2 | 4 | |
| 63323-010-42 | Gentamicin | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 4 | |
| 63323-010-94 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 4 | |
| 63323-010-95 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 4 | |
| 63323-010-96 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 3 | |
| 63323-010-96 | Gentamicin | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-010 | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 4 package rows | 20231215_a73a5453-c091-43fd-aae2-d992152363b1.zip |
| 63323-010 | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 4 | Current NDC, Legacy NDC, 4 package rows | 20231219_0cce2238-28d3-4280-b520-ffc3067a2ffa.zip |
| 63323-010 | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20241017_84f5c763-1cd3-4d85-9afb-934db8666fbf.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-010-01 | ML - Milliliter | 63323-010 | 8f7fbb9f-e4ee-4c24-9cbf-cf5bb8b1d5fa | 1 | 2021-11-09 |
| 63323-010-02 | ML - Milliliter | 63323-010 | 92538238-da65-4ed7-8897-630760fe2e7c | 1 | 2013-02-13 |
| 63323-010-03 | ML - Milliliter | 63323-010 | 19616f55-e7a5-4305-8fdd-aa5fe3efe73c | 1 | 2021-10-08 |
| 63323-010-20 | ML - Milliliter | 63323-010 | c14a0d40-777c-4160-864c-67db4bc4ef43 | 1 | 2013-02-13 |
| 63323-010-41 | ML - Milliliter | 63323-010 | 4a00898e-ee4d-42cf-ac5d-a838db4deae9 | 1 | 2021-11-09 |
| 63323-010-42 | ML - Milliliter | 63323-010 | 12f4a20a-beb2-4941-b432-2e768988c155 | 1 | 2021-11-09 |
| 63323-010-94 | ML - Milliliter | 63323-010 | 68aa80b2-bd39-4e78-ba34-50985d84379c | 1 | 2013-12-02 |
| 63323-010-95 | ML - Milliliter | 63323-010 | 2f852c4c-085f-4c84-ab61-7553ed9f830c | 1 | 2013-12-02 |
| 63323-010-96 | ML - Milliliter | 63323-010 | fc20bbf7-9d1b-4004-a475-7c44486c15dd | 1 | 2014-02-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 16474069-510b-0754-9d78-9bc0354f6549 | 2023-11-23 | Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 9e550dc9-509e-da05-8a97-ecbd0f5dd633 | 2023-11-22 | Adverse reactions | 8X7386QRLV |
| Sulphuricum acidum | SULFURIC ACID | Boiron | 8692f851-0484-fa7d-e053-2991aa0a8e57 | 2023-11-15 | O40UQP6WCF | |
| Sulphuricum acidum | SULFURIC ACID | Boiron | 8692a44d-2f50-d574-e053-2991aa0a7ee6 | 2023-11-15 | O40UQP6WCF | |
| Sulphuricum acidum | SULFURIC ACID | Boiron | 87713f93-9bd2-2fbf-e053-2995a90aaf9e | 2023-11-15 | O40UQP6WCF | |
| Sulphuricum acidum | SULFURIC ACID | Boiron | 86922572-6e29-fff4-e053-2991aa0abbd0 | 2023-11-15 | O40UQP6WCF | |
| Gentamicin | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 09cf88af-59da-f147-e063-6294a90aac99 | 2023-11-10 | Boxed warning, Warnings, Adverse reactions | ANDA062366 71872-7311-1 71872-7311 313996 09cf496c-8177-ebb7-e063-6394a90a745a 09cf88af-59da-f147-e063-6294a90aac99 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 0cce2238-28d3-4280-b520-ffc3067a2ffa | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | ANDA062366 63323-010-95 63323-010-41 63323-010-42 63323-010-94 63323-010 313996 48a57ed5-3809-49cc-a7ec-715e7e2c1720 0cce2238-28d3-4280-b520-ffc3067a2ffa 8X7386QRLV |
| Pollutox | SULPHURICUM ACIDUM, BERBERIS VULGARIS, ARSENICUM ALBUM, BENZINUM, CADMIUM SULPHURATUM, HYDROFLUORICUM ACIDUM, MELATONIN, NITROGENUM OXYGENATUM, NUX VOMICA, PETROLEUM, PLUMBUM METALLICUM, STANNUM METALLICUM, TOLUENE, ACETONE, CARBON DIOXIDE, CHLORINUM, MERCURIUS SOLUBILIS, URANIUM NITRICUM, OZONE | Deseret Biologicals, Inc. | 14a1f0a6-1b22-449c-b4dd-f8feb7215554 | 2023-10-26 | Warnings | O40UQP6WCF |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | be5b414e-d598-4721-80ee-5836156ad210 | 2023-10-24 | Boxed warning, Warnings, Adverse reactions | ANDA062366 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | a73a5453-c091-43fd-aae2-d992152363b1 | 2023-10-20 | Boxed warning, Warnings, Adverse reactions | ANDA062366 63323-010-03 63323-010-02 63323-010-01 63323-010-20 63323-010 63323001001 313996 cf4327d0-9155-4a07-9c54-51592b66b817 a73a5453-c091-43fd-aae2-d992152363b1 8X7386QRLV |
| Enviro Detox Formula | LAPPA MAJOR, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, SPINACIA, PETROLEUM, PLUMBUM METALLICUM, SULPHURICUM ACIDUM, AMMONIUM PHOSPHORICUM, ARSENICUM ALBUM, CHROMIUM (METALLICUM), CUPRUM METALLICUM, DIBROMOETHANE, KREOSOTUM, MERCURIUS VIVUS, MTBE (TERT-BUTYL METHYL ETHER), NITRICUM ACIDUM, RADIUM BROMATUM | Nutritional Specialties, Inc. | 83825312-dff8-4caa-8afa-bb1eab7397f7 | 2023-10-06 | Warnings | O40UQP6WCF |
| Gentamicin | GENTAMICIN | Hikma Pharmaceuticals USA Inc. | 51fffac8-fb6e-4f7f-b2de-440252781a42 | 2023-09-07 | Boxed warning, Warnings, Adverse reactions | 313996 8X7386QRLV |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SODIUM BICARBONATE, ALOE BARBADENSIS LEAF JUICE, IMIDAZOLIDINYL UREA | ANUBIS COSMETICS SL | ebf4b3ab-34e1-185a-e053-2a95a90ace3a | 2023-09-05 | Warnings | 059QF0KO0R |
| Lipotox | SQUALENE, CHOLESTERINUM, ESTRADIOL, PROGESTERONE, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, | BioActive Nutritional, Inc. | a1538692-ca00-4e52-9b7e-409767ee27e1 | 2023-09-05 | Warnings | Z8IX2SC1OH A2I8C7HI9T |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.